SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-23-000107
Filing Date
2023-08-11
Accepted
2023-08-11 16:17:22
Documents
82
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20230630x10q.htm   iXBRL 10-Q 4327162
2 EX-10.3 alim-20230630xex10_3.htm EX-10.3 951980
3 EX-10.4 alim-20230630xex10_4.htm EX-10.4 90218
4 EX-10.5 alim-20230630xex10_5.htm EX-10.5 198584
5 EX-31.1 alim-20230630xex31_1.htm EX-31.1 20802
6 EX-31.2 alim-20230630xex31_2.htm EX-31.2 21115
7 EX-32.1 alim-20230630xex32_1.htm EX-32.1 16022
  Complete submission text file 0001267602-23-000107.txt   16638952

Data Files

Seq Description Document Type Size
8 EX-101.SCH alim-20230630.xsd EX-101.SCH 59546
9 EX-101.CAL alim-20230630_cal.xml EX-101.CAL 69037
10 EX-101.DEF alim-20230630_def.xml EX-101.DEF 242165
11 EX-101.LAB alim-20230630_lab.xml EX-101.LAB 569341
12 EX-101.PRE alim-20230630_pre.xml EX-101.PRE 442885
76 EXTRACTED XBRL INSTANCE DOCUMENT alim-20230630x10q_htm.xml XML 3703250
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 231164377
SIC: 2834 Pharmaceutical Preparations